![Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525505021002651-gr1.jpg)
Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect
![Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update | SpringerLink Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13760-020-01488-y/MediaObjects/13760_2020_1488_Fig1_HTML.png)
Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update | SpringerLink
![Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c0036032-5790-40c7-a4c6-bf7527a74cc2/epi.2014.55.issue-8.cover.jpg?trick=1682202389581)
Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library
![Characteristics of widely used third generation antiepileptic drugs... | Download Scientific Diagram Characteristics of widely used third generation antiepileptic drugs... | Download Scientific Diagram](https://www.researchgate.net/publication/260445153/figure/fig1/AS:601664801214505@1520459475772/Characteristics-of-widely-used-third-generation-antiepileptic-drugs-for-the-treatment.png)
Characteristics of widely used third generation antiepileptic drugs... | Download Scientific Diagram
![Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial - The Lancet Neurology Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2005796345/2025318417/gr1.gif)